ALIT

Alight's stock price experienced significant volatility and an 86.02% decline from $63.80 to $8.92 between October 1, 2025, and September 30, 2026, with a 52-week trading range of $8.51 to $64.20. Key events in the past six months include a 1-for-20 reverse stock split on June 30, 2026, to address its share price falling below the NYSE's minimum threshold. In Q2 CY2026, the company announced better-than-expected revenue of $511 million, but sales declined by 3.2% year-on-year, adjusted EBITDA decreased by 27.6% year-over-year, and adjusted EPS fell to $0.91, leading to a sharp stock drop of over 20% on August 4, 2026. Additionally, Alight provided weak Q3 2026 guidance, projecting revenue below analysts' estimates. On October 1, 2026, Alight announced the acquisition of Abett. Leadership changes included Rohit Verma's appointment as CEO on January 1, 2026, and Greg Giometti's appointment as Interim CFO on January 9, 2026. Director Robert A. Lopes Jr. acquired 30,000 shares on March 15, 2026, and Marquee Health joined the Alight Partner Network on September 14, 2026.